Skip to content

In the BioHarmony Drug Report Database

Darifenacin

Enablex, Emselex (darifenacin) is a small molecule pharmaceutical. Darifenacin was first approved as Enablex on 2004-10-22. It is used to treat overactive urinary bladder and urge urinary incontinence in the USA. It has been approved in Europe to treat overactive urinary bladder and urge urinary incontinence. The pharmaceutical is active against muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M1, muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M5, and muscarinic acetylcholine receptor M4.
Trade Name Emselex
Common Name Darifenacin
Indication overactive urinary bladder, urge urinary incontinence
Drug Class Muscarinic receptor antagonists
Darifenacin
Get full access now